Related Experiment Video

Updated: Jul 16, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome

Rishi Sukhija1, Ibrahim Fahdi, Luis Garza

  • 1Division of Cardiovascular Medicine, Central Arkansas Veterans Healthcare System, and University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

The American Journal of Cardiology
|April 3, 2007
PubMed

Insights

Inflammatory markers like hs-CRP, IL-6, and TNF-alpha did not predict coronary artery disease severity or major adverse cardiac events in patients with chest pain. Traditional risk factors were more strongly associated with disease burden.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Analysis

Background:

  • Elevated inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha), are implicated in coronary artery disease (CAD) pathogenesis.
  • Previous studies suggest these markers may predict adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the predictive value of serum hs-CRP, IL-6, and TNF-alpha levels for atherosclerotic burden and major adverse cardiac events (MACEs) in patients presenting with acute chest pain.
  • To determine if inflammatory markers offer additional prognostic information beyond traditional CAD risk factors.

Main Methods:

  • Prospective study of 249 patients admitted with acute chest pain undergoing coronary angiography.
  • Serum levels of hs-CRP, IL-6, and TNF-alpha were measured.
  • Angiographic severity of CAD was assessed, and MACEs (myocardial infarction, all-cause death, revascularization) were recorded at 6-month follow-up.

Main Results:

  • No significant association was found between hs-CRP, IL-6, or TNF-alpha levels and the angiographic severity of CAD after adjusting for traditional risk factors.
  • Age, male gender, diabetes mellitus, and hypercholesterolemia showed a significant positive correlation with atherosclerotic burden.
  • Serum inflammatory marker levels were not significantly associated with MACEs at 6 months in either unadjusted or adjusted models.

Conclusions:

  • In patients hospitalized with acute chest pain, serum levels of hs-CRP, IL-6, and TNF-alpha do not appear to be associated with coronary atherosclerotic burden.
  • These inflammatory markers did not predict major adverse cardiac events at 6 months in this cohort, even after accounting for conventional CAD risk factors.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...